Possible Future Solutions for Slowing, Stopping, or Eradicating Alzheimer’s Disease

Alzheimer’s disease is, understandably, one of the most feared diseases of old age. It robs people of their memories, places a tremendous strain on caregivers, and imposes a huge economic burden on both individuals and society. Tens of millions of people have already been diagnosed with Alzheimer’s, and if predictions are correct, that number will more than double by 2050.

Until recently, it seemed there was no hope of averting this catastrophe, but rapid advances in medical science have made it realistic prospects that Alzheimer’s may be treatable and eventually eradicated (see “A new kind of vaccine could lead to Alzheimer’s eradication”).

The first of a new class of drugs is already creating buzz, but not necessarily for the right reasons. Last week, the UK’s Medicines and Healthcare products Regulatory Agency approved the drug, called lecanemab. But NICE, the body that advises on whether new treatments are cost-effective, has made a provisional decision that taxpayers will not fund the drug in England. No decision has yet been made in the rest of the UK.

This is obviously a tough pill to swallow for Alzheimer’s patients and their families. But in the grand scheme of things, this is good news. Lecanemab is not a particularly effective drug. Its effects are modest, it has serious side effects, and it is expensive. But it does show that the causes of Alzheimer’s are now understood and treatable. This is further reinforced by the fact that the drug is also approved in the United States and Japan, but the European Medicines Agency has refused to approve it.

So the way is almost paved for the next wave of drugs to target the causes of Alzheimer’s, which could be ready around 2030. These are vaccines, not in the traditional sense of conferring immunity against an infection, but they work in essentially the same way, by stimulating an immune response against the misfolded proteins that cause the symptoms of Alzheimer’s. The first vaccines will be therapeutic, slowing or stopping the progression of Alzheimer’s, but the next generation will be preventative, preventing the onset of Alzheimer’s. Eventually, the only memory that will fade will be Alzheimer’s itself.

Source: www.newscientist.com

Insecticides are ineffective for eradicating cockroaches in commercial settings.

Cockroaches are a common pest

Lerachanok/Shutterstock

People buying insecticide sprays to get rid of cockroaches are wasting money because the bugs have developed a resistance to the key ingredients, prompting calls for U.S. regulators to tighten product testing rules.

There are about 30 species of cockroaches living around humans, but the German cockroach (German cockroachThe common dust mite ( ), found worldwide, is the dust mite most likely to infest buildings. Previous research There is evidence of widespread resistance to pyrethroid insecticides, which are commonly found in consumer products.

now, Jonalyn Gordon University of Florida researchers found that while commercial insecticides continue to work effectively on lab-derived German cockroaches bred from strains that have not been exposed to insecticides, they are ineffective against insects taken from real-world infestations.

The products are designed to be sprayed on surfaces to kill insects that walk across them, but in the team's tests, the coated surfaces killed fewer than 20 percent of the cockroaches they collected after 20 minutes of exposure. “Spraying these products directly in a closed container did not result in a 100 percent kill rate,” Gordon says.

When cockroaches were forced to remain on treated surfaces, most products took between eight and 24 hours to kill them. Previous research In reality, this is unlikely to occur, as these insects have been shown to avoid landing on pyrethroid-treated surfaces.

Pest-control products sold in the United States are regulated by the Environmental Protection Agency and manufacturers must prove they are 90 percent effective, but field testing on insects is not generally required.

That needs to change, Gordon says, noting that any bedbug-control products sold in the US should be required to be tested on recently collected specimens. “If that were to happen for cockroach control, I think it would raise the bar for cockroach-control products and ensure that the products on the shelves are providing the control people reasonably expect,” Gordon says.

In the meantime, cockroach repellents are probably the most effective consumer product for controlling pests, with the added benefit of minimizing human exposure to pesticides, Gordon says. Home measures like eliminating food and water sources the pests use and cleaning up clutter can also help. Professional pest control using non-pyrethroid insecticides is also recommended.

topic:

Source: www.newscientist.com

Genetic technology capable of eradicating superweeds through targeted plant destruction

Herbicide-resistant pigweed is a serious problem for farmers

Design Pics Inc / Alamy Stock Photo

Gene drives – bits of DNA that trick evolution and can spread even if they are harmful – have been successfully tested in plants for the first time. This approach can be used to clear out invasive plants and superweeds without harming other species, potentially reducing herbicide use. It could also help save species by spreading genes that make them more resistant to disease and better able to cope with global warming.

Genes work by distorting the probability that an organism will inherit a piece of DNA. Most plants and animals have two copies of each gene. This usually means that there is a 50% chance that a particular copy will be passed on to offspring. With a gene drive, the chance increases to, say, 80 percent, allowing genes to spread even if they are harmful.

There are many natural gene drives that function through different mechanisms. In 2013, the first artificial gene drive was created using CRISPR gene editing technology.

It copies itself from one chromosome to another. That is, all descendants inherit it. This approach is called a homing gene drive because the drive itself is copied to a specific site.

bruce hay The researchers at the California Institute of Technology used a different approach called cleave-and-rescue. The gene drive consists of CRISPR elements that target and destroy copies of both key genes needed for pollen and egg formation. However, the drive also contains a version of this gene that functions without being destroyed.

This means that pollen and eggs that do not inherit the gene drive will lack important genes and will not develop. Only pollen and eggs with the gene drive will develop normally, so all offspring will inherit it.

Hay says the cleave-and-rescue approach is more robust than homing drives because it's much easier to destroy genes than to copy and paste them. He says it works on all animals, not just plants, and could be used to rid islands of rats and mice that are wiping out native species.

Hay's team tested a working version of this drive – one designed only to spread, not kill – on Thale cress. Arabidopsis.Another team led by Yang Liu Chinese Academy of Sciences Even in Beijing I have submitted a paper describing a similar gene drive But that approach isn't as powerful, Hay says.

He and his team are currently planning driving tests in Pigweed (amaranth palmeri), a herbicide-resistant superweed and a major problem for farmers in many parts of the world. “This is the poster child for developing broad-based resistance to all existing herbicides,” Hay says.

Additionally, this technology could be adapted to control weeds without spreading indefinitely. For example, pollen could be used to create male plants that kill all female offspring. Planting these male plants annually around the farm will prevent seed production and eradicate the weed species from the field after a few years.

“If you just exclude women, you end up collapsing the entire local population, but not the global population,” Hay says. However, this female-killing trait will disappear if no male plants with it are planted.

Hay said this approach is much more likely to be approved by regulators than gene drives, which continue to spread until resistance emerges. In fact, a similar approach is already being used in several countries by a company called Oxitec to control malaria-carrying mosquitoes.

but, paul nave Researchers at the University of Copenhagen in Denmark doubt whether regulators will approve the use of gene drives to control weeds. “I think the chances of getting approval to release gene drives for agricultural use are low at this point. Healthcare and biodiversity conservation may be an easier sell,” he says.

Another big problem, Neve says, is that plants typically produce only one generation per year, and it takes 10 to 30 generations for drives to become widespread. “How can we spread gene drives fast enough to achieve meaningful weed control in a realistic time frame?”

topic:

Source: www.newscientist.com